ArticleTherapeutic advances in medical oncology2021

Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study.

Tai-Jan Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.